nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB1—periodontitis	0.972	1	CbGaD
Bupranolol—Gemfibrozil—PPARA—periodontitis	0.00317	0.265	CrCbGaD
Bupranolol—ADRB3—Adrenoceptors—ADRB1—periodontitis	0.00249	0.155	CbGpPWpGaD
Bupranolol—ADRB2—Adrenoceptors—ADRB1—periodontitis	0.00144	0.09	CbGpPWpGaD
Bupranolol—Pirbuterol—ADRB1—periodontitis	0.00114	0.0957	CrCbGaD
Bupranolol—Levobunolol—ADRB1—periodontitis	0.00102	0.0853	CrCbGaD
Bupranolol—Timolol—ADRB1—periodontitis	0.000974	0.0814	CrCbGaD
Bupranolol—ADRB3—Monoamine GPCRs—ADRB1—periodontitis	0.00088	0.0548	CbGpPWpGaD
Bupranolol—Carteolol—ADRB1—periodontitis	0.000868	0.0725	CrCbGaD
Bupranolol—Nadolol—ADRB1—periodontitis	0.000773	0.0646	CrCbGaD
Bupranolol—Clenbuterol—ADRB1—periodontitis	0.000746	0.0624	CrCbGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—ADRB1—periodontitis	0.00074	0.0461	CbGpPWpGaD
Bupranolol—Clenbuterol—TNF—periodontitis	0.000708	0.0592	CrCbGaD
Bupranolol—Bopindolol—ADRB1—periodontitis	0.000707	0.0591	CrCbGaD
Bupranolol—Salbutamol—ADRB1—periodontitis	0.000694	0.058	CrCbGaD
Bupranolol—Penbutolol—ADRB1—periodontitis	0.000675	0.0564	CrCbGaD
Bupranolol—ADRB2—Monoamine GPCRs—ADRB1—periodontitis	0.000511	0.0318	CbGpPWpGaD
Bupranolol—Pindolol—ADRB1—periodontitis	0.000486	0.0407	CrCbGaD
Bupranolol—ADRB3—G alpha (s) signalling events—VIP—periodontitis	0.000442	0.0276	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—ADRB1—periodontitis	0.000429	0.0268	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—ADRB1—periodontitis	0.000305	0.019	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—CXCR2—periodontitis	0.000293	0.0183	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000292	0.0182	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—MET—periodontitis	0.000275	0.0171	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.000263	0.0164	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—VIP—periodontitis	0.000262	0.0164	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—VIP—periodontitis	0.000257	0.016	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL3—periodontitis	0.000222	0.0138	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000219	0.0137	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000188	0.0117	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—ADRB1—periodontitis	0.000177	0.011	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000173	0.0108	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000171	0.0106	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00017	0.0106	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000169	0.0106	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.000153	0.00953	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000146	0.00911	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000145	0.00907	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCR2—periodontitis	0.000143	0.00892	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL3—periodontitis	0.000132	0.00821	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00013	0.00811	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL3—periodontitis	0.000129	0.00804	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000127	0.00794	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL3—periodontitis	0.000125	0.00782	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL3—periodontitis	0.000114	0.0071	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000112	0.00695	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR2—periodontitis	0.000111	0.00694	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRB1—periodontitis	0.000111	0.0069	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000109	0.0068	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000101	0.00631	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	9.9e-05	0.00617	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	9.86e-05	0.00614	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—VIP—periodontitis	9.07e-05	0.00565	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	8.67e-05	0.00541	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCR2—periodontitis	8.49e-05	0.00529	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	8.49e-05	0.00529	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	8.45e-05	0.00526	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCR2—periodontitis	8.31e-05	0.00518	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—VIP—periodontitis	8.24e-05	0.00513	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCR2—periodontitis	8.09e-05	0.00504	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL3—periodontitis	7.45e-05	0.00464	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCR2—periodontitis	7.34e-05	0.00458	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL3—periodontitis	7.29e-05	0.00454	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	7.2e-05	0.00449	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL3—periodontitis	6.76e-05	0.00422	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL3—periodontitis	6.73e-05	0.0042	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL3—periodontitis	6.62e-05	0.00412	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR2—periodontitis	6.61e-05	0.00412	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR2—periodontitis	6.46e-05	0.00403	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADRB1—periodontitis	6.43e-05	0.00401	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR2—periodontitis	6.29e-05	0.00392	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRB1—periodontitis	6.26e-05	0.0039	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR2—periodontitis	5.71e-05	0.00356	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.69e-05	0.00355	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB1—periodontitis	5.69e-05	0.00354	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL2—periodontitis	5.48e-05	0.00342	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—VIP—periodontitis	5.39e-05	0.00336	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—VIP—periodontitis	5.27e-05	0.00328	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—VIP—periodontitis	4.89e-05	0.00305	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VIP—periodontitis	4.87e-05	0.00303	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCR2—periodontitis	4.8e-05	0.00299	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—VIP—periodontitis	4.78e-05	0.00298	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCR2—periodontitis	4.7e-05	0.00293	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCR2—periodontitis	4.36e-05	0.00272	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCR2—periodontitis	4.34e-05	0.0027	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL8—periodontitis	4.34e-05	0.0027	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MMP3—periodontitis	4.33e-05	0.0027	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	4.27e-05	0.00266	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCR2—periodontitis	4.26e-05	0.00266	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	4.18e-05	0.00261	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL3—periodontitis	4e-05	0.00249	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL3—periodontitis	3.91e-05	0.00244	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR2—periodontitis	3.73e-05	0.00233	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR2—periodontitis	3.65e-05	0.00228	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRB1—periodontitis	3.64e-05	0.00227	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR2—periodontitis	3.39e-05	0.00211	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.38e-05	0.00211	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR2—periodontitis	3.37e-05	0.0021	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB1—periodontitis	3.36e-05	0.00209	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR2—periodontitis	3.32e-05	0.00207	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.31e-05	0.00206	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRB1—periodontitis	3.3e-05	0.00206	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL2—periodontitis	3.25e-05	0.00203	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL2—periodontitis	3.18e-05	0.00198	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VIP—periodontitis	2.89e-05	0.0018	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VIP—periodontitis	2.83e-05	0.00176	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL2—periodontitis	2.81e-05	0.00175	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NTRK1—periodontitis	2.75e-05	0.00171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR2—periodontitis	2.57e-05	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—periodontitis	2.57e-05	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MMP3—periodontitis	2.57e-05	0.0016	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP3—periodontitis	2.56e-05	0.00159	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR2—periodontitis	2.52e-05	0.00157	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—periodontitis	2.52e-05	0.00157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MMP3—periodontitis	2.51e-05	0.00157	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—periodontitis	2.45e-05	0.00153	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—periodontitis	2.23e-05	0.00139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR2—periodontitis	2e-05	0.00125	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR2—periodontitis	1.96e-05	0.00122	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRB1—periodontitis	1.95e-05	0.00122	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—periodontitis	1.67e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—periodontitis	1.66e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—periodontitis	1.63e-05	0.00102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NTRK1—periodontitis	1.63e-05	0.00102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NTRK1—periodontitis	1.6e-05	0.000995	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP3—periodontitis	1.52e-05	0.000946	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—periodontitis	1.5e-05	0.000936	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP3—periodontitis	1.48e-05	0.000925	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	1.45e-05	0.000906	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	1.42e-05	0.000887	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—periodontitis	1.32e-05	0.000823	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—periodontitis	1.31e-05	0.000819	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—periodontitis	1.29e-05	0.000805	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—periodontitis	1.25e-05	0.000779	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—periodontitis	1.19e-05	0.000741	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—periodontitis	9.87e-06	0.000615	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—periodontitis	9.8e-06	0.000611	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—periodontitis	9.65e-06	0.000602	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—periodontitis	8.92e-06	0.000556	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—periodontitis	8.72e-06	0.000544	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—periodontitis	7.8e-06	0.000486	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—periodontitis	7.63e-06	0.000476	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—periodontitis	7.42e-06	0.000462	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—periodontitis	7.38e-06	0.00046	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—periodontitis	7.26e-06	0.000452	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—periodontitis	7.06e-06	0.00044	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—periodontitis	6.9e-06	0.00043	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—periodontitis	5.82e-06	0.000362	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—periodontitis	5.69e-06	0.000355	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—periodontitis	4.38e-06	0.000273	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—periodontitis	4.29e-06	0.000267	CbGpPWpGaD
